1947 Effect of oral cyclophosphamide use on pathologic complete response rate in theneoadjuvant treatment of breast cancer

Complete Response ◽

Oral Cyclophosphamide ◽

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Oncotarget ◽

10.18632/oncotarget.25413 ◽

2018 ◽

Vol 9 (41) ◽

pp. 26406-26416 ◽

Cited By ~ 36

Author(s):

Angela Santonja ◽

Alfonso Sánchez-Muñoz ◽

Ana Lluch ◽

Maria Rosario Chica-Parrado ◽

Joan Albanell ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Cancer Subtypes ◽

Abstract P3-11-14: Circulating lymphocytes and pathologic complete response rate among patients with early stage triple negative breast cancer treated with neoadjuvant chemotherapy

10.1158/1538-7445.sabcs18-p3-11-14 ◽

2019 ◽

Author(s):

SM Talamantes ◽

RL Costa ◽

A Rademaker ◽

CA Santa-Maria

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Early Stage ◽

Complete Response ◽

Circulating Lymphocytes ◽

Abstract P1-14-13: Increased Pathologic Complete Response Rate and Reduced Tumour RNA Levels Upon Treatment of Locally Advanced Breast Cancer with Neoadjuvant Concurrent Chemotherapy and Radiation

10.1158/0008-5472.sabcs12-p1-14-13 ◽

2012 ◽

Author(s):

M Brackstone ◽

A Chambers ◽

B Guo ◽

T Vandenberg ◽

K Potvin ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Response Rate ◽

Complete Response Rate ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Complete Response ◽

Concurrent Chemotherapy ◽

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer

OncoImmunology ◽

10.1080/2162402x.2016.1207032 ◽

2016 ◽

Vol 6 (9) ◽

pp. e1207032 ◽

Cited By ~ 12

Author(s):

Lea Lowenfeld ◽

Salman Zaheer ◽

Crystal Oechsle ◽

Megan Fracol ◽

Jashodeep Datta ◽

...

Keyword(s):

Breast Cancer ◽

Immune Response ◽

Dendritic Cell ◽

Response Rate ◽

Complete Response Rate ◽

Estrogen Therapy ◽

Complete Response ◽

Dendritic Cell Vaccination ◽

Abstract PD07-03: INCREASED PATHOLOGIC COMPLETE RESPONSE RATE AFTER A LONG TERM NEOADJUVANT LETROZOLE TREATMENT IN POSTMENOPAUSAL ESTROGEN AND/OR PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER

10.1158/0008-5472.sabcs12-pd07-03 ◽

2012 ◽

Author(s):

G Allevi ◽

C Strina ◽

D Andreis ◽

V Zanoni ◽

L Bazzola ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Letrozole Treatment ◽

Postmenopausal Estrogen ◽

439 Significantly Higher Pathologic Complete Response Rate with Weekly Compared with Three-weekly Paclitaxel and Carboplatin Plus Trastuzumab Neoadjuvant Therapy – Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer

European Journal of Cancer ◽

10.1016/s0959-8049(12)70505-1 ◽

2012 ◽

Vol 48 ◽

pp. S175

Author(s):

Z.M. Shao ◽

C.M. Chen ◽

Y. Zhou ◽

S. Chen ◽

Y.F. Hou ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Response Rate ◽

Complete Response Rate ◽

Growth Factor Receptor ◽

Complete Response ◽

Epidermal Growth ◽

Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06110-0 ◽

2021 ◽

Author(s):

M. E. Tesch ◽

S. K. Chia ◽

C. E. Simmons ◽

N. LeVasseur

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Breast Cancer Patients ◽

Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors

Brazilian Journal of Medical and Biological Research ◽

10.1590/1414-431x20165674 ◽

2017 ◽

Vol 50 (2) ◽

Cited By ~ 5

Author(s):

I.P.C. Buzatto ◽

A. Ribeiro-Silva ◽

J.M. Andrade ◽

H.H.A. Carrara ◽

W.A. Silveira ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Her2 Positive ◽

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05295-9 ◽

2019 ◽

Vol 177 (1) ◽

pp. 61-66 ◽

Cited By ~ 5

Author(s):

Melissa Krystel-Whittemore ◽

Jin Xu ◽

Edi Brogi ◽

Katia Ventura ◽

Sujata Patil ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Detection Methods ◽

Her2 Positive ◽

Neoadjuvant Systemic Therapy ◽

Abstract P1-14-17: Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience

10.1158/1538-7445.sabcs15-p1-14-17 ◽

2016 ◽

Author(s):

JC Singh ◽

S Sugarman ◽

L Jones ◽

C Boafo ◽

S Patil ◽

...

Keyword(s):

Breast Cancer ◽

Response Rate ◽

Complete Response Rate ◽

Early Stage ◽

Complete Response ◽

Early Stage Breast Cancer ◽

Single Institution ◽

Her2 Positive ◽